Singapore at a glance
- Population
- 6.1 million 2025
- Life expectancy at birth
- 83.3 years, 2024
- People aged 65 and over
- 14.2 % of people, 2025
- Health spending per person
- 3,922 US$ per person, 2023
- Doctors
- 2.83 per 1,000 people, 2022
Updated
Reviewed by Vidhi Upadhyay
Singapore Breath Diagnostics Market Industry Trends and Forecast to 2034: Segmented by (Application, Technology, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$3.0 Mn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $1.4 Mn | — | — |
| 2025 (base) | $1.5 Mn | +$0.2 Mn | — |
| 2026 (forecast) | $1.7 Mn | +$0.2 Mn | +12.8% |
| 2027 (forecast) | $1.9 Mn | +$0.2 Mn | +27.2% |
| 2028 (forecast) | $2.2 Mn | +$0.2 Mn | +43.5% |
| 2029 (forecast) | $2.5 Mn | +$0.3 Mn | +61.9% |
| 2030 (forecast) | $2.8 Mn | +$0.3 Mn | +82.6% |
| 2031 (forecast) | $3.1 Mn | +$0.4 Mn | +106% |
| 2032 (forecast) | $3.5 Mn | +$0.4 Mn | +132.4% |
| 2033 (forecast) | $4.0 Mn | +$0.5 Mn | +162.1% |
| 2034 (forecast) | $4.5 Mn | +$0.5 Mn | +195.7% |
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
| Market size, 2025 | $1.5 Mn placeholder estimate |
|---|---|
| Forecast, 2034 | $4.5 Mn placeholder estimate |
| Growth (CAGR), 2025–2034 | 12.8% placeholder estimate |
| Years | 2024 historical · 2025 base year · 2026–2034 forecast |
| Segments | Application, technology and end user (see all) |
| Key players | Owlstone Medical, Circassia (NIOX), Exalenz Bioscience, Kibion, Breathtec Biomedical (see all) |
| Regulator in Singapore | HSASource: Health Sciences Authority. Checked 14 Nov 2026. |
| Formats | PDF, PPTX, XLSX |
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
Breath diagnostics analyse molecules in exhaled breath to detect diseases such as H. pylori infection, asthma and some cancers.
Key segments of the breath Diagnostics market include application (H. pylori Testing, Asthma (FeNO) and Gut Disorders) and technology (Urea Breath Tests, FeNO Analyzers and Mass Spectrometry).
Demand for earlier and faster diagnosis, growth of testing outside hospitals, new molecular technologies and the shift to preventive care are driving the breath Diagnostics market.
Home testing, connected devices that send results to doctors and multiplex tests that check many conditions at once give the breath Diagnostics market room to grow, especially in emerging markets.
Pricing pressure, uneven reimbursement for new tests, regulatory approval times and the need for skilled lab staff hold back the breath Diagnostics market.
The breath Diagnostics market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
Medical devices must be registered with the Health Sciences Authority (HSA), except low-risk Class A devices.[1] MediShield Life gives basic health insurance to all citizens and permanent residents, alongside MediSave savings accounts.[2]
[1] Health Sciences Authority. Checked 14 Nov 2026.
[2] CPF Board, MediShield Life. Checked 14 Nov 2026.
Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how breath Diagnostics products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in Singapore.
What doctors and scientists are doing in Breath Diagnostics right now, from free public sources.
Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 16 Nov 2026.
[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 17 Nov 2026.
[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 16 Nov 2026.
From our blog
Singapore
Singapore
Singapore
Singapore
Singapore
Singapore
Digital Health · Singapore
Healthcare Services · Singapore
OTC & Nutraceuticals · Singapore
Healthcare Services · Singapore
Pharmaceuticals · Singapore
Pharmaceuticals · Singapore